Concepedia

Considering temozolomide as a novel potential treatment for esophageal cancer

Céline Bruyère, Caroline Lonez, Anaëlle Duray, Stéphanie Cludts, Jean‐Marie Ruysschaert, Sven Saussez, Paul Yeaton, Róbert Kiss, Tatjana Mijatovic

Cancer · 2010 · 26 citations · 29 references

DOI

Abstract

The current study emphasized the role of proangiogenic chemokines in esophageal cancer biology and indicated the possibility of using TMZ as a clinically compatible drug to impair the actions of the CXCL chemokine network in esophageal cancers.

References

29

Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells

Takao Kanzawa, Isabelle M. Germano, Tadashi Komata et al. · Cell Death and Differentiation · 2004 · 978 citations · Full text

Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine

Wynand P. Roos, Luís F.Z. Batista, Steffen C. Naumann et al. · Oncogene · 2006 · 493 citations

, , +9

DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells

Makoto Katayama, Tomohiro Kawaguchi, Mitchel S. Berger et al. · Cell Death and Differentiation · 2006 · 353 citations · Full text

, , +9

Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer

Jussuf T. Kaifi, Emre F. Yekebas, Paulus Schurr et al. · JNCI Journal of the National Cancer Institute · 2005 · 218 citations · Full text

A Growth-Related Oncogene/CXC Chemokine Receptor 2 Autocrine Loop Contributes to Cellular Proliferation in Esophageal Cancer

Bo Wang, Denver T. Hendricks, Fred Wamunyokoli et al. · Cancer Research · 2006 · 188 citations